THE HPV VACCINE: What does it mean for women in the U.S.?

Human papillomavirus (HPV) is the most common sexually transmitted infection (STI) in the U.S., consisting of over 100 strains,of which 40 affect the genital areas. Even though 90% of all infections are asymptomatic and HPV rarely leads to cervical cancer, the HPV vaccine Gardasil has been marketed heavily as „the cervical cancer vaccine“. Merck & Co. estimated between US $ 1.4 billion and US $ 1.6 billion in 2008 sales. This poster focuses on critically questioning whether the HPV vaccination is an appropriate preventive measure for cervical cancer in the U.S. A comparative analysis shows the difference in pap test and HPV vaccine in regards to cost, detection of cervical abnormalities, prevention of cervical cancer, and overall effectiveness of both preventive measures. Also, the gender aspect of the marketing of HPV vaccination is explored. Conclusion: Merck & Co. branded Gardasil® a cervical cancer vaccine, rather than an STI prevention tool to increase marketability. Cervical cancer is a 'rare' disease in the U.S.; why mandate an expensive vaccine with unknown long-term effects? It would be safer, and cheaper, to set up programs ensuring that all girls and women are screened regularly for cervical cancer.